Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 2, 2006

View Archived Issues

BYK-191023: new selective iNOS inhibitor and candidate for inflammatory hypotension

Meta-analysis indicates beneficial effects of Chinese herbal medicine for NSCLC

Recent patents describe novel analgesic agents

A new role for Cdk5 in pain signaling

Enrollment ahead of schedule in Onconase phase IIIb study

AVI signs HCV license agreement with Chiron

Daiichi reports new agents for treating allergic disorders

Novel ophthalmic compounds described by Alcon in a recent patent

Recent patents disclose novel agents for cardiovascular disorders

PKC-412 and AMN-107 show promise in systemic mastocytosis with mutated KIT

MediGene and Bradley sign agreement for Polyphenon E Ointment

Pharmion and MethylGene sign agreement for oncology oral HDAC inhibitors

Synergistic activity seen with FK-228 and bortezomib in leukemic cells

AOD-9604 shows potential for osteoporosis

Ferring and Astellas sign licensing agreement for degarelix in Japan

BTG acquires rights to Asterand's pain compounds

Orphan drug designation for TheraQuest's high-concentration capsaicin

Benitec delays IND filing for HIV/AIDS therapeutic

SNS-032 begins phase I study in advanced solid tumor cancers

Phase II trial planned for Cloretazine in elderly poor-risk AML patients

Locus and Lilly enter research agreement

FDA accepts IND for OxyQD

Enrollment completed in phase II stress urinary incontinence study of cizolirtine

U.S. launch for Avandaryl

Amitiza approved for chronic idiopathic constipation

GlaxoSmithKline's Arranon launched for the first time in the U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...